Hematologic (blood) cancers, which impact the normal production and function of blood cells, often begin in bone marrow where stem cells develop into white blood cells, red blood cells, or platelets. These types of cancers occur when an uncontrolled growth of abnormal cells overtakes the development of normal blood cells, interfering with the regular functions of those cells. Hematologic cancers can be classified into three categories: leukemia, lymphoma, and multiple myeloma.
Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio. Leverage our recent research and explore practical, actionable resources that you can implement in your cancer program today.
The MRD Implementation Roadmaps initiative will help multidisciplinary community cancer care teams better comprehend MRD testing by addressing barriers to incorporating the test into the treatment of ALL, CLL, and MM.
Acute lymphocytic leukemia (ALL), also known as acute lymphoblastic leukemia, is a cancer of the blood and bone marrow.
Chronic lymphocytic leukemia (CLL) is a cancer of the B-lymphocytes that may be found in the bone marrow, blood, lymph nodes, spleen and sometimes other organs. CLL is the most common leukemia in adults and accounts for one quarter of new leukemia cases annually.
Multiple myeloma is the third most common hematologic cancer. However, compared to more frequently occurring cancers, multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year.
Diffuse large B-cell lymphoma (DLBCL), is an aggressive disease affecting B-lymphocytes. There are many novel therapies and combination regimens currently being studied in clinical trials for the treatment of both newly diagnosed and relapsed/refractory DLBCL.
This project will teaches multidisciplinary cancer care teams about what they should anticipate as vaccinations slowly make it possible for them to resume pre-pandemic services—specifically for patients with hematologic malignancies.
Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves.
In this episode, we'll hear how patients with blood cancer are joining the LLS National Patient Registry to increase scientific knowledge about COVID-19 vaccination and booster shot efficacy.
As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.
Three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care.
ACCC has invited providers across the U.S. to discuss the unique challenges seen in their respective regions and address how the current state of cancer care for patients with chronic lymphocytic leukemia (CLL) may be improved.
Oral oncolytic treatment represents a new wave of intervention by providing patients with CLL the means to self-administer medications at home, allowing patients a degree of control over their treatment.
Six on-demand recordings hosted by multidisciplinary faculty explore various dispensing models and effective practices in the care of patients with multiple myeloma.
Hear considerations for treating patients with CLL during the pandemic, including best options, treatment timing, changes to the usual regimen, and how to prepare for the future.
The pandemic has heightened the distress patients with CLL face and taken its toll on providers. Learn strategies and solutions to these challenges and the path forward for providing patient care.
Panelists discussed considerations for resuming pre-pandemic level visits and procedures for patients with CLL, AML, and Multiple Myeloma. Hear wins and challenges in providing care in a pandemic.
Digital toolkits offer resources and tools to support the multidisciplinary cancer team in providing quality care for patients.
Real-world case studies enable cancer programs to reflect on current practices to reduce variations in care and positively impact patient outcomes.
Multiple Myeloma Dispensing Models: Effective Practices to Improve Care Delivery and the Patient Experience
Real-world case studies from University of Illinois Hospital and Health Services System, Miami Cancer Institute at Baptist Health South Florida, and John Theurer Cancer Center at Hackensack University Medical Center, analyze and summarize their existing dispensing models and practices in caring for patients with multiple myeloma.
Multidisciplinary Chronic Lymphocytic Leukemia Care: Quality Improvement Case Studies
The Outer Banks Hospital, Billings Clinic Cancer Center, and the Ohio State University Comprehensive Cancer Center participated in quality improvement workshops in 2020.
Multidisciplinary Chronic Lymphocytic Leukemia Care: Models of Effective Care Delivery
To understand how patient-focused multidisciplinary care is effectively delivered across care settings, ACCC conducted site-visit focus groups at Self Regional Healthcare Cancer Center, The University of Kansas Cancer Center, and Sunrise Hospital and Medical Center.
Multidisciplinary Multiple Myeloma Care: Models of Effective Care Delivery
ACCC spoke with care team members at Yuma Regional Medical Center Cancer Center, John Theurer Cancer Center at Hackensack University Medical Center, and Moffitt Cancer Center to better understand how cancer centers are incorporating a multidisciplinary approach to diagnosing and managing patients with multiple myeloma.